These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15288572

  • 1. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
    Kelley BG, Thayer SA.
    Eur J Pharmacol; 2004 Aug 02; 496(1-3):33-9. PubMed ID: 15288572
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
    Cippitelli A, Bilbao A, Gorriti MA, Navarro M, Massi M, Piomelli D, Ciccocioppo R, Rodríguez de Fonseca F.
    Eur J Neurosci; 2007 Jul 02; 26(2):476-86. PubMed ID: 17650118
    [Abstract] [Full Text] [Related]

  • 4. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats.
    Trezza V, Vanderschuren LJ.
    J Pharmacol Exp Ther; 2009 Jan 02; 328(1):343-50. PubMed ID: 18948500
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A, Beltramo M, Piomelli D.
    J Pharmacol Exp Ther; 2001 Jul 02; 298(1):7-14. PubMed ID: 11408519
    [Abstract] [Full Text] [Related]

  • 6. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
    Rodella LF, Borsani E, Rezzani R, Ricci F, Buffoli B, Bianchi R.
    Eur J Pharmacol; 2005 Jan 31; 508(1-3):139-46. PubMed ID: 15680264
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V, Kendall DA, Jerman JC, Middlemiss DN, Smart D.
    Eur J Pharmacol; 2001 Jul 27; 424(3):211-9. PubMed ID: 11672565
    [Abstract] [Full Text] [Related]

  • 8. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.
    Jonsson KO, Andersson A, Jacobsson SO, Vandevoorde S, Lambert DM, Fowler CJ.
    Arch Toxicol; 2003 Apr 27; 77(4):201-7. PubMed ID: 12698235
    [Abstract] [Full Text] [Related]

  • 9. The anandamide transport inhibitor AM404 activates vanilloid receptors.
    Zygmunt PM, Chuang H, Movahed P, Julius D, Högestätt ED.
    Eur J Pharmacol; 2000 May 12; 396(1):39-42. PubMed ID: 10822052
    [Abstract] [Full Text] [Related]

  • 10. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.
    Kim SR, Lee DY, Chung ES, Oh UT, Kim SU, Jin BK.
    J Neurosci; 2005 Jan 19; 25(3):662-71. PubMed ID: 15659603
    [Abstract] [Full Text] [Related]

  • 11. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
    Guo J, Ikeda SR.
    Mol Pharmacol; 2004 Mar 19; 65(3):665-74. PubMed ID: 14978245
    [Abstract] [Full Text] [Related]

  • 12. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.
    Brain Res Mol Brain Res; 2004 Dec 06; 132(1):87-92. PubMed ID: 15548432
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
    Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulié P, Piomelli D.
    Eur J Pharmacol; 2000 Nov 17; 408(2):161-8. PubMed ID: 11080522
    [Abstract] [Full Text] [Related]

  • 15. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.
    Beltramo M, de Fonseca FR, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G, Sadile AG, Giuffrida A, Piomelli D.
    J Neurosci; 2000 May 01; 20(9):3401-7. PubMed ID: 10777802
    [Abstract] [Full Text] [Related]

  • 16. The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels.
    Alptekin A, Galadari S, Shuba Y, Petroianu G, Oz M.
    Eur J Pharmacol; 2010 May 25; 634(1-3):10-5. PubMed ID: 20171208
    [Abstract] [Full Text] [Related]

  • 17. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
    Rockwell CE, Kaminski NE.
    J Pharmacol Exp Ther; 2004 Nov 25; 311(2):683-90. PubMed ID: 15284281
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of anandamide hypotension by the transport inhibitor, AM404.
    Calignano A, La Rana G, Beltramo M, Makriyannis A, Piomelli D.
    Eur J Pharmacol; 1997 Oct 15; 337(1):R1-2. PubMed ID: 9389389
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
    Lam FF, Luk PW, Ng ES.
    Life Sci; 2007 Mar 27; 80(16):1495-502. PubMed ID: 17275857
    [Abstract] [Full Text] [Related]

  • 20. The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes.
    Oz M, Ravindran A, Diaz-Ruiz O, Zhang L, Morales M.
    J Pharmacol Exp Ther; 2003 Sep 27; 306(3):1003-10. PubMed ID: 12766252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.